{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T19:43:02Z","timestamp":1789846982361,"version":"4.0.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82001357"],"award-info":[{"award-number":["No. 82001357"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 2020JJ5951"],"award-info":[{"award-number":["No. 2020JJ5951"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 2021JJ80079"],"award-info":[{"award-number":["No. 2021JJ80079"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Youth Science Foundation of Xiangya Hospital","award":["No. 2019Q17"],"award-info":[{"award-number":["No. 2019Q17"]}]},{"name":"Degree & Postgraduate Education Reform Project of Central South University","award":["No. 2021YJSKSA10"],"award-info":[{"award-number":["No. 2021YJSKSA10"]}]},{"name":"Undergraduate Education Reform Project of Central South University","award":["No. 2021CG065"],"award-info":[{"award-number":["No. 2021CG065"]}]},{"name":"Undergraduate Education Reform Project of Central South University","award":["No. 2021CG068"],"award-info":[{"award-number":["No. 2021CG068"]}]},{"name":"Research Project of Laboratory Construction and Management of Central South University","award":["No. 202120"],"award-info":[{"award-number":["No. 202120"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s10072-022-06192-8","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T04:02:56Z","timestamp":1655092976000},"page":"5301-5312","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Polymorphism of neurodegeneration-related genes associated with Parkinson\u2019s disease risk"],"prefix":"10.1007","volume":"43","author":[{"given":"Jiaxin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minhan","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujuan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zini","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0577-7129","authenticated-orcid":false,"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,13]]},"reference":[{"issue":"12 Pt 2","key":"6192_CR1","doi-asserted-by":"publisher","first-page":"155s","DOI":"10.1592\/phco.27.12part2.155S","volume":"27","author":"M Lew","year":"2007","unstructured":"Lew M (2007) Overview of Parkinson\u2019s disease. Pharmacotherapy 27(12 Pt 2):155s\u2013160s","journal-title":"Pharmacotherapy"},{"issue":"5","key":"6192_CR2","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.biocel.2004.09.009","volume":"37","author":"SJ Chinta","year":"2005","unstructured":"Chinta SJ, Andersen JK (2005) Dopaminergic neurons. Int J Biochem Cell Biol 37(5):942\u2013946","journal-title":"Int J Biochem Cell Biol"},{"issue":"3 Suppl 1","key":"6192_CR3","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1016\/j.metabol.2014.10.030","volume":"64","author":"DB Miller","year":"2015","unstructured":"Miller DB, O\u2019Callaghan JP (2015) Biomarkers of Parkinson\u2019s disease: present and future. Metabolism 64(3 Suppl 1):S40\u2013S46","journal-title":"Metabolism"},{"issue":"2","key":"6192_CR4","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/(SICI)1096-8628(19970418)74:2<154::AID-AJMG7>3.0.CO;2-U","volume":"74","author":"P Costa","year":"1997","unstructured":"Costa P et al (1997) Association of a polymorphism in intron 13 of the monoamine oxidase B gene with Parkinson disease. Am J Med Genet 74(2):154\u2013156","journal-title":"Am J Med Genet"},{"issue":"3","key":"6192_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3109\/10408368009108731","volume":"12","author":"RA Rush","year":"1980","unstructured":"Rush RA, Geffen LB (1980) Dopamine beta-hydroxylase in health and disease. Crit Rev Clin Lab Sci 12(3):241\u2013277","journal-title":"Crit Rev Clin Lab Sci"},{"key":"6192_CR6","doi-asserted-by":"publisher","unstructured":"Yenisetti SC (2018) Parkinson\u2019s disease - understanding pathophysiology and developing therapeutic strategies || effects of genetic variability in dopaminergic pathway on treatment response in Parkinson\u2019s disease. https:\/\/doi.org\/10.5772\/intechopen.70111(Chapter 3).","DOI":"10.5772\/intechopen.70111(Chapter"},{"key":"6192_CR7","doi-asserted-by":"publisher","first-page":"675725","DOI":"10.3389\/fphar.2021.675725","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu Y et al (2021) FGF, mechanism of action, role in Parkinson\u2019s disease, and therapeutics. Front Pharmacol 12:675725","journal-title":"Front Pharmacol"},{"issue":"30","key":"6192_CR8","doi-asserted-by":"publisher","first-page":"15226","DOI":"10.1073\/pnas.1821409116","volume":"116","author":"W Paslawski","year":"2019","unstructured":"Paslawski W et al (2019) \u03b1-synuclein-lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson\u2019s disease patients. Proc Natl Acad Sci U S A 116(30):15226\u201315235","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6192_CR9","doi-asserted-by":"crossref","unstructured":"Zhou ZD, Sathiyamoorthy S, Tan EK (2012) LINGO-1 and neurodegeneration: pathophysiologic clues for essential tremor. Tremor Other Hyperkinet Mov (N Y), 2.","DOI":"10.5334\/tohm.111"},{"issue":"3","key":"6192_CR10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ et al (1992) Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181\u2013184","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"6192_CR11","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30(12):1591\u20131601","journal-title":"Mov Disord"},{"key":"6192_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-2288-14-45","volume":"14","author":"CK Lo","year":"2014","unstructured":"Lo CK, Mertz D, Loeb M (2014) Newcastle-Ottawa Scale: comparing reviewers\u2019 to authors\u2019 assessments. BMC Med Res Methodol 14:45","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"6192_CR13","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/jcmm.12751","volume":"20","author":"F Zhao","year":"2016","unstructured":"Zhao F et al (2016) Genetic model. J Cell Mol Med 20(4):765","journal-title":"J Cell Mol Med"},{"key":"6192_CR14","doi-asserted-by":"crossref","unstructured":"Cacabelos R (2017) Parkinson\u2019s disease: from pathogenesis to pharmacogenomics. Int J Mol Sci 18(3).","DOI":"10.3390\/ijms18030551"},{"issue":"4","key":"6192_CR15","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/01616412.2018.1564183","volume":"41","author":"YC Wang","year":"2019","unstructured":"Wang YC et al (2019) COMT Val158Met polymorphism and Parkinson\u2019s disease risk: a pooled analysis in different populations. Neurol Res 41(4):319\u2013325","journal-title":"Neurol Res"},{"issue":"5","key":"6192_CR16","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3109\/00207454.2015.1028057","volume":"126","author":"Y Zhang","year":"2016","unstructured":"Zhang Y et al (2016) A meta-analysis on relationship of MAOB intron 13 polymorphisms, interactions with smoking\/COMT H158L polymorphisms with the risk of PD. Int J Neurosci 126(5):400\u2013407","journal-title":"Int J Neurosci"},{"issue":"10","key":"6192_CR17","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.1007\/s10072-021-05509-3","volume":"42","author":"Y Yin","year":"2021","unstructured":"Yin Y et al (2021) Association of COMT rs4680 and MAO-B rs1799836 polymorphisms with levodopa-induced dyskinesia in Parkinson\u2019s disease-a meta-analysis. Neurol Sci 42(10):4085\u20134094","journal-title":"Neurol Sci"},{"issue":"1","key":"6192_CR18","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1159\/000495238","volume":"51","author":"S Tang","year":"2018","unstructured":"Tang S et al (2018) Association of dopamine beta-hydroxylase polymorphisms with Alzheimer\u2019s disease, Parkinson\u2019s disease and Schizophrenia: evidence based on currently available loci. Cell Physiol Biochem 51(1):411\u2013428","journal-title":"Cell Physiol Biochem"},{"issue":"12","key":"6192_CR19","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1007\/s10072-018-3543-7","volume":"39","author":"S Kang","year":"2018","unstructured":"Kang S et al (2018) Association of the rs1611115 polymorphism in DBH gene with Parkinson\u2019s disease: a meta-analysis. Neurol Sci 39(12):2085\u20132089","journal-title":"Neurol Sci"},{"key":"6192_CR20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.neulet.2019.05.015","volume":"706","author":"A Ghosh","year":"2019","unstructured":"Ghosh A et al (2019) Dopamine \u03b2 Hydroxylase (DBH) is a potential modifier gene associated with Parkinson\u2019s disease in Eastern India. Neurosci Lett 706:75\u201380","journal-title":"Neurosci Lett"},{"key":"6192_CR21","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1100\/2011\/172893","volume":"11","author":"M Politis","year":"2011","unstructured":"Politis M, Loane C (2011) Serotonergic dysfunction in Parkinson\u2019s disease and its relevance to disability. ScientificWorldJournal 11:1726\u20131734","journal-title":"ScientificWorldJournal"},{"issue":"4","key":"6192_CR22","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s13760-020-01342-1","volume":"121","author":"P Cheng","year":"2021","unstructured":"Cheng P et al (2021) 5-HTTLPR polymorphism and depression risk in Parkinson\u2019s disease: an updated meta-analysis. Acta Neurol Belg 121(4):933\u2013940","journal-title":"Acta Neurol Belg"},{"issue":"7","key":"6192_CR23","doi-asserted-by":"publisher","first-page":"e01008","DOI":"10.1002\/brb3.1008","volume":"8","author":"KE McDonell","year":"2018","unstructured":"McDonell KE et al (2018) Taq1A polymorphism and medication effects on inhibitory action control in Parkinson disease. Brain Behav 8(7):e01008","journal-title":"Brain Behav"},{"issue":"12","key":"6192_CR24","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1002\/mds.22678","volume":"24","author":"JY Lee","year":"2009","unstructured":"Lee JY et al (2009) Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson\u2019s disease. Mov Disord 24(12):1803\u20131810","journal-title":"Mov Disord"},{"key":"6192_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12883-015-0316-2","volume":"15","author":"S Zainal Abidin","year":"2015","unstructured":"Zainal Abidin S et al (2015) DRD and GRIN2B polymorphisms and their association with the development of impulse control behaviour among Malaysian Parkinson\u2019s disease patients. BMC Neurol 15:59","journal-title":"BMC Neurol"},{"issue":"3","key":"6192_CR26","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.neuron.2012.11.033","volume":"77","author":"DA MacLeod","year":"2013","unstructured":"MacLeod DA et al (2013) RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson\u2019s disease risk. Neuron 77(3):425\u2013439","journal-title":"Neuron"},{"key":"6192_CR27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.neulet.2017.08.022","volume":"657","author":"T He","year":"2017","unstructured":"He T et al (2017) Association between PARK16 and Parkinson\u2019s disease: a meta-analysis. Neurosci Lett 657:179\u2013188","journal-title":"Neurosci Lett"},{"issue":"6","key":"6192_CR28","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1002\/ajmg.b.32454","volume":"171","author":"AA Gopalai","year":"2016","unstructured":"Gopalai AA et al (2016) PARK16 is associated with PD in the Malaysian population. Am J Med Genet B Neuropsychiatr Genet 171(6):839\u2013847","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"1","key":"6192_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41531-021-00179-6","volume":"7","author":"KM Miller","year":"2021","unstructured":"Miller KM, Mercado NM, Sortwell CE (2021) Synucleinopathy-associated pathogenesis in Parkinson\u2019s disease and the potential for brain-derived neurotrophic factor. NPJ Parkinsons Dis 7(1):35","journal-title":"NPJ Parkinsons Dis"},{"issue":"3","key":"6192_CR30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s12017-019-08548-4","volume":"21","author":"P Pal","year":"2019","unstructured":"Pal P et al (2019) Role of apolipoprotein E, cathepsin D, and brain-derived neurotrophic factor in Parkinson\u2019s disease: a study from Eastern India. Neuromolecular Med 21(3):287\u2013294","journal-title":"Neuromolecular Med"},{"key":"6192_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fnmol.2013.00015","volume":"6","author":"N Itoh","year":"2013","unstructured":"Itoh N, Ohta H (2013) Roles of FGF20 in dopaminergic neurons and Parkinson\u2019s disease. Front Mol Neurosci 6:15","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"6192_CR32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10072-014-1884-4","volume":"36","author":"ZG Ma","year":"2015","unstructured":"Ma ZG, Xu J, Liu TW (2015) Quantitative assessment of the association between fibroblast growth factor 20 rs1721100 C\/G polymorphism and the risk of sporadic Parkinson\u2019s diseases: a meta-analysis. Neurol Sci 36(1):47\u201351","journal-title":"Neurol Sci"},{"issue":"4","key":"6192_CR33","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41582-020-0335-5","volume":"16","author":"I Fyfe","year":"2020","unstructured":"Fyfe I (2020) APOE(*)\u03b54 promotes synucleinopathy. Nat Rev Neurol 16(4):185","journal-title":"Nat Rev Neurol"},{"issue":"12","key":"6192_CR34","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1212\/01.WNL.0000130159.28215.6A","volume":"62","author":"X Huang","year":"2004","unstructured":"Huang X, Chen PC, Poole C (2004) APOE-[epsilon]2 allele associated with higher prevalence of sporadic Parkinson disease. Neurology 62(12):2198\u20132202","journal-title":"Neurology"},{"issue":"2","key":"6192_CR35","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3233\/JPD-150762","volume":"6","author":"KC Paul","year":"2016","unstructured":"Paul KC et al (2016) APOE, MAPT, and COMT and Parkinson\u2019s disease susceptibility and cognitive symptom progression. J Parkinsons Dis 6(2):349\u2013359","journal-title":"J Parkinsons Dis"},{"issue":"6","key":"6192_CR36","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00702-016-1552-3","volume":"123","author":"D Robakis","year":"2016","unstructured":"Robakis D et al (2016) The effect of MAPT haplotype on neocortical Lewy body pathology in Parkinson disease. J Neural Transm (Vienna) 123(6):583\u2013588","journal-title":"J Neural Transm (Vienna)"},{"issue":"2","key":"6192_CR37","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.neurobiolaging.2013.07.027","volume":"35","author":"SP Millard","year":"2014","unstructured":"Millard SP et al (2014) Association of cerebrospinal fluid A\u03b242 with A2M gene in cognitively normal subjects. Neurobiol Aging 35(2):357\u2013364","journal-title":"Neurobiol Aging"},{"issue":"3","key":"6192_CR38","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3109\/00207454.2014.996641","volume":"126","author":"X Guo","year":"2016","unstructured":"Guo X et al (2016) Association between two alpha-2-macroglobulin gene polymorphisms and Parkinson\u2019s disease: a meta-analysis. Int J Neurosci 126(3):193\u2013198","journal-title":"Int J Neurosci"},{"issue":"4","key":"6192_CR39","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00438-018-1451-4","volume":"293","author":"Y Daneshmandpour","year":"2018","unstructured":"Daneshmandpour Y, Darvish H, Emamalizadeh B (2018) RIT2: responsible and susceptible gene for neurological and psychiatric disorders. Mol Genet Genomics 293(4):785\u2013792","journal-title":"Mol Genet Genomics"},{"key":"6192_CR40","doi-asserted-by":"publisher","first-page":"13805","DOI":"10.1038\/srep13805","volume":"5","author":"Y Lu","year":"2015","unstructured":"Lu Y et al (2015) Genetic association of RIT2 rs12456492 polymorphism and Parkinson\u2019s disease susceptibility in Asian populations: a meta-analysis. Sci Rep 5:13805","journal-title":"Sci Rep"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-06192-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-022-06192-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-06192-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T04:12:15Z","timestamp":1660709535000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-022-06192-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,13]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["6192"],"URL":"https:\/\/doi.org\/10.1007\/s10072-022-06192-8","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,13]]},"assertion":[{"value":"10 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}